Vall d'Hebron Institute of Oncology
At the VHIO, doctors and scientists come together in multidisciplinary teams in order to provide improvements in the field of oncological diseases, and translate discoveries into medical benefits. More than 200 researchers and healthcare staff are dedicated to understanding the way cancer works, from biology and genetics to treatment.
Through translational research, knowledge resulting from research can be used to prevent and treat cancer. The symbiosis between VHIO and the hospital, this constant dialogue between patients and research, reduces the gap between laboratory results and patient care.
VHIO activity is divided into four main programmes: preclinical, translational, clinical and core technologies research; all focused on offering cancer patients less aggressive and more personalised treatments. Vall d’Hebron Campus has great potential, providing direct access to its whole range of oncology professionals and possible treatments.
The winning proposal for the transformation of the Vall d’Hebron Campus is the project directed by Jordi Badia, Antoni Ubach and Miquel Espinet. The project presented by the architects includes a new research building for the Vall d'Hebron Research Institute, with an expandable area of 5,000 m2 and a budget of €15 million funded by ERDF (European Regional Development Fund).
The Vall d’Hebron Medical Oncology Department witnessed a vital moment in its trajectory when Dr. Josep Baselga joined in 1996. He laid the first stone of the current Department, now directed by Dr. Josep Tabernero, and converted the hospital into a world-leading centre.